An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Abstract Malignant cancer angiogenesis has historically attracted enormous scientific attention. Although angiogenesis is requisite for a child’s development and conducive to tissue homeostasis, it is deleterious when cancer lurks. Today, anti-angiogenic biomolecular receptor tyrosine kinase inhibit...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-04-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-32850-8 |
| _version_ | 1797836501426372608 |
|---|---|
| author | Syed Anas Ansar Shruti Aggarwal Swati Arya Mohd. Anul Haq Vikas Mittal Fikreselam Gared |
| author_facet | Syed Anas Ansar Shruti Aggarwal Swati Arya Mohd. Anul Haq Vikas Mittal Fikreselam Gared |
| author_sort | Syed Anas Ansar |
| collection | DOAJ |
| description | Abstract Malignant cancer angiogenesis has historically attracted enormous scientific attention. Although angiogenesis is requisite for a child’s development and conducive to tissue homeostasis, it is deleterious when cancer lurks. Today, anti-angiogenic biomolecular receptor tyrosine kinase inhibitors (RTKIs) to target angiogenesis have been prolific in treating various carcinomas. Angiogenesis is a pivotal component in malignant transformation, oncogenesis, and metastasis that can be activated by a multiplicity of factors (e.g., VEGF (Vascular endothelial growth factor), (FGF) Fibroblast growth factor, (PDGF) Platelet-derived growth factor and others). The advent of RTKIs, which primarily target members of the VEGFR (VEGF Receptor) family of angiogenic receptors has greatly ameliorated the outlook for some cancer forms, including hepatocellular carcinoma, malignant tumors, and gastrointestinal carcinoma. Cancer therapeutics have evolved steadily with active metabolites and strong multi-targeted RTK inhibitors such as E7080, CHIR-258, SU 5402, etc. This research intends to determine the efficacious anti-angiogenesis inhibitors and rank them by using the Preference Ranking Organization Method for Enrichment Evaluation (PROMETHEE- II) decision-making algorithm. The PROMETHEE-II approach assesses the influence of growth factors (GFs) in relation to the anti-angiogenesis inhibitors. Due to their capacity to cope with the frequently present vagueness while ranking alternatives, fuzzy models constitute the most suitable tools for producing results for analyzing qualitative information. This research’s quantitative methodology focuses on ranking the inhibitors according to their significance concerning criteria. The evaluation findings indicate the most efficacious and idle alternative for inhibiting angiogenesis in cancer. |
| first_indexed | 2024-04-09T15:10:01Z |
| format | Article |
| id | doaj.art-b37cf0a83cf24bd0bb8050bd9bd943e8 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-09T15:10:01Z |
| publishDate | 2023-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-b37cf0a83cf24bd0bb8050bd9bd943e82023-04-30T11:16:32ZengNature PortfolioScientific Reports2045-23222023-04-0113111410.1038/s41598-023-32850-8An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosisSyed Anas Ansar0Shruti Aggarwal1Swati Arya2Mohd. Anul Haq3Vikas Mittal4Fikreselam Gared5Department of Computer Application, Babu Banarasi Das UniversityDepartment of Computer Science and Engineering, Thapar Institute of Engineering and TechnologyDepartment of Computer Application, Babu Banarasi Das UniversityDepartment of Computer Science, College of Computer and Information Sciences, Majmaah UniversityDepartment of Electronics and Communication Engineering, Chandigarh UniversityFaculty of Electrical and Computer Engineering, Bahir Dar Institute of Technology, Bahir Dar UniversityAbstract Malignant cancer angiogenesis has historically attracted enormous scientific attention. Although angiogenesis is requisite for a child’s development and conducive to tissue homeostasis, it is deleterious when cancer lurks. Today, anti-angiogenic biomolecular receptor tyrosine kinase inhibitors (RTKIs) to target angiogenesis have been prolific in treating various carcinomas. Angiogenesis is a pivotal component in malignant transformation, oncogenesis, and metastasis that can be activated by a multiplicity of factors (e.g., VEGF (Vascular endothelial growth factor), (FGF) Fibroblast growth factor, (PDGF) Platelet-derived growth factor and others). The advent of RTKIs, which primarily target members of the VEGFR (VEGF Receptor) family of angiogenic receptors has greatly ameliorated the outlook for some cancer forms, including hepatocellular carcinoma, malignant tumors, and gastrointestinal carcinoma. Cancer therapeutics have evolved steadily with active metabolites and strong multi-targeted RTK inhibitors such as E7080, CHIR-258, SU 5402, etc. This research intends to determine the efficacious anti-angiogenesis inhibitors and rank them by using the Preference Ranking Organization Method for Enrichment Evaluation (PROMETHEE- II) decision-making algorithm. The PROMETHEE-II approach assesses the influence of growth factors (GFs) in relation to the anti-angiogenesis inhibitors. Due to their capacity to cope with the frequently present vagueness while ranking alternatives, fuzzy models constitute the most suitable tools for producing results for analyzing qualitative information. This research’s quantitative methodology focuses on ranking the inhibitors according to their significance concerning criteria. The evaluation findings indicate the most efficacious and idle alternative for inhibiting angiogenesis in cancer.https://doi.org/10.1038/s41598-023-32850-8 |
| spellingShingle | Syed Anas Ansar Shruti Aggarwal Swati Arya Mohd. Anul Haq Vikas Mittal Fikreselam Gared An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis Scientific Reports |
| title | An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis |
| title_full | An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis |
| title_fullStr | An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis |
| title_full_unstemmed | An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis |
| title_short | An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis |
| title_sort | intuitionistic approach for the predictability of anti angiogenic inhibitors in cancer diagnosis |
| url | https://doi.org/10.1038/s41598-023-32850-8 |
| work_keys_str_mv | AT syedanasansar anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT shrutiaggarwal anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT swatiarya anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT mohdanulhaq anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT vikasmittal anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT fikreselamgared anintuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT syedanasansar intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT shrutiaggarwal intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT swatiarya intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT mohdanulhaq intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT vikasmittal intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis AT fikreselamgared intuitionisticapproachforthepredictabilityofantiangiogenicinhibitorsincancerdiagnosis |